American Journal of Ophthalmology
Volume 146, Issue 6 , Pages 866-875.e2 , December 2008

Photoreceptor Oxidative Damage in Sympathetic Ophthalmia

,Accepted 30 March 2008.

References 

  1. Rathinam SR, Rao NA. Sympathetic ophthalmia following postoperative bacterial endophthalmitis: a clinicopathologic study. Am J Ophthalmol. 2006;141:498–507
  2. Ward TP. Sympathetic ophthalmia. In:  Lounsbury DE,  Bellamy RF,  Zajtchuk R,  Thach AB editor. Ophthalmic care of the combat casualty. Washington, DC: Dept. of the Army; 2003;p. 265–279
  3. Rao NA, Robin J, Hartman D, Sweeney JA, Marak GE. The role of the penetrating wound in the development of sympathetic ophthalmia. Arch Ophthalmol. 1983;101:102–104
  4. Kitaichi N, Kotake S, Morohashi T, Onoe K, Ohno S, Taylor AW. Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J Leukoc Biol. 2002;72:1117–1121
  5. Wu GS, Lee TD, Moore RE, Rao NA. Photoreceptor mitochondrial tyrosine nitration in experimental uveitis. Invest Ophthalmol Vis Sci. 2005;46:2271–2281
  6. Wu GS, Zhang J, Rao NA. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 1997;38:1333–1339
  7. Ito S, Wu GS, Kimoto T, Hisatomi T, Ishibashi T, Rao NA. Peroxynitrite-induced apoptosis in photoreceptor cells. Curr Eye Res. 2004;28:17–24
  8. Rajendram R, Saraswathy S, Rao NA. Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91:531–537
  9. Yue G, Lai PS, Yin K, et al. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production. J Pharmacol Exp Ther. 2001;297:915–925
  10. Li HL, Sun BZ, Ma FC. Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol. 2004;10:1862–1866
  11. Yamawaki H, Lehoux S, Berk BC. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation. 2003;108:1619–1625
  12. Okubo A, Rosa RH, Bunce CV, et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci. 1999;40:443–449
  13. Croxato JO, Rao NA, McLean IW, Marak GE. Atypical histopathologic features in sympathetic ophthalmia (A study of a hundred cases). Int Ophthalmol. 1982;4:129–135
  14. Ramadan A, Nussenblatt RB. Visual prognosis and sympathetic ophthalmia. Curr Opin Ophthalmol. 1996;7:39–45
  15. Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci. 2005;46:4245–4250
  16. Sartani G, Silver PB, Rizzo LV, et al. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest Ophthalmol Vis Sci. 1996;37:2211–2218
  17. Nakamura S, Yamakawa T, Sugita M, et al. The role of tumor necrosis factor-alpha in the induction of experimental uveoretinitis in mice. Invest Ophthalmol Vis Sci. 1994;35:3884–3889
  18. Franks WA, Limb GA, Stanford MR, et al. Cytokines in human intraocular inflammation. Curr Eye Res. 1992;11:187–191
  19. Song W, Lu X, Feng Q. Tumor necrosis factor-α induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res. 2000;45:595–603
  20. Zhang L, Peppel K, Sivashanmugam P, et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:1087–1094
  21. Palexas GN, Sussman G, Welsh NH. Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation. Scand J Immunol Suppl. 1992;11:173–175
  22. Lisdero CL, Carreras MC, Meulemans A, et al. The mitochondrial interplay of ubiquinol and nitric oxide in endotoxemia. Methods Enzymol. 2004;382:67–81
  23. Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci U S A. 1993;90:3024–3027
  24. Carreras MC, Franco MC, Peralta JG, Poderoso JJ. Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol Aspects Med. 2004;25:125–139
  25. Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys. 1985;237:408–414
  26. Vasquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA, Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry. 1997;36:11293–11297
  27. Crow JP, Beckman JS. The importance of superoxide in nitric oxide-dependent toxicity: evidence of peroxynitrite-mediated injury. Adv Exp Med Biol. 1996;387:147–161
  28. Valdez LB, Alvarez S, Arnaiz SL, et al. Reactions of peroxynitrite in the mitochondrial matrix. Free Radic Biol Med. 2000;29:349–356
  29. Radi R. Peroxynitrite reactions and diffusion in biology. Chem Res Toxicol. 1998;11:720–721
  30. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell. 1996;86:147–157
  31. Han Z, Hendrickson EA, Bremner TA, Wyche JH. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem. 1997;272:13432–13436
  32. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome C by direct inhibition of distinct caspases. EMBO J. 1998;17:2215–2223
  33. Tanel A, Averill-Bates DA. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta. 2005;1743:255–267
  34. Lim ML, Lum MG, Hansen TM, Roucou X, Nagley P. On the release of cytochrome C from mitochondria during cell death signaling. J Biomed Sci. 2002;9:488–506
  35. Abu El-Asrar AM, Struyf S, van den Broeck C, et al. Expression of chemokines and gelatinase B in sympathetic ophthalmia. Eye. 2007;21:649–657
  36. Murray PI, Sivaraj RR. Anti-TNF-α therapy for uveitis: Behcet and beyond. Eye. 2005;19:831–833
  37. Vazquez-Cobian LB, Flynn T, Lehman TJ. Adalimumab therapy for childhood uveitis. J Pediatr. 2006;149:572–575

PII: S0002-9394(08)00257-2

doi: 10.1016/j.ajo.2008.03.026

American Journal of Ophthalmology
Volume 146, Issue 6 , Pages 866-875.e2 , December 2008

Article Tools

* Image Usage & Resolution